Jump to main content
Jump to site search
PLANNED MAINTENANCE Close the message box

Scheduled maintenance upgrade on Thursday 4th of May 2017 from 8.00am to 9.00am (BST).

During this time our websites will be offline temporarily. If you have any questions please use the feedback button on this page. We apologise for any inconvenience this might cause and thank you for your patience.



Mesoporous Nanocarriers with Stimulus-Responsive Cyclodextrin Gatekeeper for Targeting Tumor Hypoxia

Abstract

Tissue hypoxia developed in most malignant tumors makes significant difference to normal tissues in the reduction potential and the activity of various bioreductive enzymes. Given the superior enzymatic activity of NAD(P)H:quinone oxidoreductase 1 (NQO1, a cytosolic reductase up-regulated in many human cancers) in hypoxia relative to that in normoxia, NQO1 has great potential for targeting hypoxic tumor cells. In the present report, the core concept of the hypoxic NQO1-responsive mesoporous silica nanoparticles (MSNs) is based on the reasoning that the superior enzymatic activity of NQO1 within hypoxic cancer cells can be utilized as a key stimulus for selective cleavage of an azobenzene stalk triggering the on-off gatekeeping for controlled release of guest drugs. We corroborate that the NQO1 specifically triggers to release the entrapped drug in the nanochannel of MSNs by reductive cleavage of azobenzene linker only under hypoxic conditions in a controlled manner not only in vitro but also in vivo. Therefore, our results indicate that Si-Azo-CD-PEG could be utilized as a hypoxic cancer-targeting drug delivery carrier, and further suggest that the azobenzene linker could be generally useful for the construction of hypoxic NQO1-responsive nanomaterials.

Back to tab navigation
Please wait while Download options loads

Supplementary files

Publication details

The article was received on 03 Feb 2017, accepted on 16 Apr 2017 and first published on 19 Apr 2017


Article type: Paper
DOI: 10.1039/C7NR00808B
Citation: Nanoscale, 2017, Accepted Manuscript
  •   Request permissions

    Mesoporous Nanocarriers with Stimulus-Responsive Cyclodextrin Gatekeeper for Targeting Tumor Hypoxia

    J. Lee, E. Oh, H. Yoon, C. W. Kim, Y. Han, J. Song, H. Jang, H. J. Park and C. Kim, Nanoscale, 2017, Accepted Manuscript , DOI: 10.1039/C7NR00808B

Search articles by author